Friend, most glove counter owner also sbb their share price at peak. did the counter shoot up ? don't buy and sell based on director activity la plus, i don't think many short term trader in this counter anymore.
I think that's the main problem of this counter... The price react like the company is depending on the compensation to survive... But you know they're suing the GOM which may takes years to resolve... There's still a case management after 2 to 3 years into the lawsuit... Price did not react even there's good earning and huge contract.. What if they drag again??
Thanks EVO118. Of course, we can't rely on the compensation only to survive in the market. Having a huge pile in bank is not necessary the company will do well but we need more project and less expenditure to get the company keep going.
I just don't see this company doing well in term of cloud service. They had alot of engagement with Google and other yet nothing positive from their side. Let see after 1st April and looking forward to it.
The never ending saga of Awantech. How do they manage to get away doing this? Why can't they just get into it and make a decision. Are the GOM going to pay interest in compensation for the additional lost time should the court case goes against them? Surely there must be a valid case for lost opportunity cost due to actions of the GOM in consistently postponing this.
It was ONLY suppose to be a case management not a full court case. They only need a court registra ( no judge ) with both sides of the litigation to hammer it out to see if they can come to an agreement or need to settle it in court with a judge.
A case management is an alternative to getting an out of court settlement. In the event it does not happen then we will get the long process of a court hearing before a final decision as well as the amount to be determined if needed.
We refer to our announcement dated 15 April 2019 and series of subsequent announcements thereafter in relation to the legal proceedings by PSKIN against the GOM.
The Company wishes to announce that during the case management held today, the next hearing date has been scheduled on 4 July 2022 in respect of PSKIN’s application to hold a discussion between costs experts.
The Company will make the necessary announcements on material developments in respect of this matter from time to time.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....